Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy.
Lucia BresciniGianluca MorroniChiara ValerianiSefora CastellettiMarina MingoiaSerena SimoniAnnamaria MasucciRoberto MontaltiMarco VivarelliAndrea GiacomettiFrancesco BarchiesiPublished in: BMC infectious diseases (2019)
This study confirmed a high mortality rate of KPC-Kp BSIs. The outcome is heavily influenced by the patient's clinical conditions. A therapeutic approach including a combination with at least two active drugs in vitro can improve the prognosis, unless patients received an appropriate therapy.
Keyphrases
- klebsiella pneumoniae
- multidrug resistant
- escherichia coli
- end stage renal disease
- chronic kidney disease
- ejection fraction
- prognostic factors
- primary care
- peritoneal dialysis
- type diabetes
- cardiovascular events
- stem cells
- case report
- coronary artery disease
- cardiovascular disease
- bone marrow
- mesenchymal stem cells